Image-guided IMRT is a revolutionary concept whose clinical implementation is rapidly evolving. Methods of executing beam intensity modulation have included individually designed compensators, static multi-leaf collimators (MLC), dynamic MLC, and sequential (serial) tomotherapy. We have developed helical tomotherapy as an innovative solution to overcome some of the limitations of other IMRT systems. The unique physical design of helical tomotherapy allows the realization of the concepts of adaptive radiotherapy and conformal avoidance. In principle, these advances should improve normal tissue sparing and permit dose reconstruction and verification, thereby allowing significant biologically effective dose escalation.
Recent radiobiological findings can be translated into altered fractionation schemes that aim to improve the local control and long-term survival. This strategy is being tested at the University of Wisconsin using helical tomotherapy with its highly precise delivery and verification system along with meticulous and practical forms of immobilization. Innovative techniques such optical guidance, respiratory gating, and ultrasound assessments are being designed and tailored for helical tomotherapy use. The intrinsic capability of helical tomotherapy for megavoltage CT (MVCT) imaging for IMRT image-guidance is being optimized.
The unique features of helical tomotherapy might allow implementation of image-guided IMRT that was previously impossible or impractical. Here we review the technological, physical, and radiobiological rationale for the ongoing and upcoming clinical trials that will use image-guided IMRT in the form of helical tomotherapy; and we describe our plans for testing our hypotheses in a rigorous prospective fashion.
MackieT. R.KapatoesJ.RuchalaK.Image-guidance for Precise Conformal Radiotherapy. Int. J. Rad. Oncol. Biol. Phys.56, 89–105 (2003).
2.
WelshJ. S.PatelR. R.RitterM. A.HarariP.MackieT. R.MehtaM. P.Helical Tomotherapy: An Innovative Technology and Approach to Radiation Therapy. Technol. Canc. Res. Treat.1, 55–63 (2002).
3.
MackieT. R.BalogJ.RuchalaK.Tomotherapy. Sem. Radiat. Onc.9, 108–117 (1999).
4.
WelshJ. S.HowardS. P.FowlerJ. P.Dose-rate in External Beam Radiotherapy for Prostate Cancer — An Overlooked Confounding Variable?Urology.62, 204–206 (2003).
5.
FowlerJ. F.WelshJ. S.HowardS. P.Loss of Biological Effect in Prolonged Fraction Delivery. Int. J. Radiat. Oncol. Biol. Phys.59, 242–249 (2004).
6.
LowD. A.MuticS.DempseyJ. F.Abutment Region Dosimetry for Serial Tomotherapy. Int. J. Radiat. Oncol. Biol. Phys.45, 193–203 (1999).
7.
CarolM.BleierA. R.The Field-matching Problem as it Applies to the Peacock Three-dimensional Conformal System for Intensity Modulation. Int. J. Radiat. Oncol. Biol. Phys.34, 183–187 (1996).
8.
YanD.LockmanD.BrabbinsD.TyburskiL.MartinezA.An Off-line Strategy for Constructing a Patient-specific Planning Target volume in Adaptive Treatment Process for Prostate Cancer. Int. J. Radiat. Oncol. Biol. Phys.48, 289–302 (2000).
9.
OliveraG. H.FitchardR. R.ReckwerdtP. J.Delivery Modification as an Alternative to Patient Repositioning in Tomothrapy. Proc. 13th Int Conf on the Use of Computers in Radiation Therapy, pp. 297–299. Eds., SchelgelW. and BorfeldT.. Heidelberg (2000).
10.
WelshJ. S.BradleyK.ManonR.LockM.PatelR.RuchalaK.MackieT. R.MehtaM.Megavoltage CT Imaging for Adaptive Helical Tomotherapy of Lung Cancer. Clinical Lung Cancer5, 303–306 (2004).
11.
RuchalaK.OliveraG.ForrestL.Megavoltage CT for Image-guided Radiotherapy. Radiotherapy and Oncology64 (Suppl.1), S12 (2002).
12.
KapatoesJ. M.OliveraG. H.ReckwerdtP. J.Delivery Verification in Sequential and Helical Tomotherapy. Phys. Med. Biol.44, 1815–1841 (1999).
13.
KapatoesJ. M.OliveraG. H.BalogJ. P.On the Accuracy and Effectiveness of Dose Reconstruction for Tomotherapy. Phys. Med. Biol.46, 943–966 (2001).
14.
Van DykeJ.BarnettR. B.CyglerJ.Commissioning and Quality Assurance of Treatment Planning Computers. Int. J. Radiat. Oncol. Biol. Phys.26, 261–273 (1993).
15.
LowD. A.HarmsW. B.MuticS.A Technique for the Quantitative Evaluation of Dose Distributions. Med. Phys.25, 656–661 (1998).
16.
HugueninP. U.TausskyD.MoeK.Quality of Life in Patients Cured from a Carcinoma of the Head and Neck by Radiotherapy: The Importance of the Target volume. Int. J. Radiat. Oncol. Biol. Phys.45, 47–52 (1999).
17.
ChaoK. S.Protection of Salivary Function by Intensity-modulated Radiation Therapy in Patients with Head and Neck Cancer. Sem. Radiat. Oncol.12 (S1), 20–25 (2002).
18.
WardeP.O'SullivanB.AslanidisJ.A Phase III Placebo-controlled Trial of Oral Pilocarpine in Patients Undergoing Radiotherapy for Head-and-Neck Cancer. Int. J. Radiat. Oncol. Biol. Phys.54, 9–13 (2002).
19.
GuchelaarH. J.VermesA.MeerwaldtJ. H.Radiation-induced Xerostomia: Pathophysiology, Clinical Course and Supportive Treatment. Supportive Care in Cancer5, 281–288 (1997).
20.
BrizelD. M.WassermanT. H.HenkeM.Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer. J. Clin. Oncol.18, 3339–3345 (2000).
21.
KanekoM.ShiratoH.NishiokaT.Scintigraphic Evaluation of Long-term Salivary Gland Function after Bilateral Whole Parotid Gland Irradiation in Radiotherapy for Head and Neck Tumour. Oral Oncol.34, 140–146 (1998).
22.
EisbruchA.KimH. M.TerrellJ. E.Xerostomia and its Predictors Following Parotid-sparing Irradiation of Head-and-Neck Cancer. Int. J. Radiat. Oncol. Biol. Phys.50, 695–704 (2001).
23.
ButlerE. B.TheB. S.GrantW. H.SMART (Simultaneous Modulated Accelerated Radiation Therapy) Boost: A New Accelerated Fractionation Schedule for the Treatment of Head and Neck Cancer with Intensity Modulated Radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.45, 21–32 (1999).
24.
NowakP. J.WijersO. B.LagerwaardF. J.A Three-dimensional CT-based Target Definition for Elective Irradiation of the Neck. Int. J. Rad. Oncol. Biol. Phys.45, 33–39 (1999).
25.
WijersO. B.LevendagP. C.TanT.A Simplified CT-based Definition of the Lymph Node Levels in the Node-negative Neck. Radiother. Oncol.52, 35–42 (1999).
26.
AngK. K.ThamesH. D.What Can be Expected from Elective Regional Radiotherapy?Can. J. Sci. Am.5, 75–76 (1999).
AdamsW. M.MillerP. E.VailD. M.An Accelerated Technique for Irradiation of Malignant Canine Nasal and Paranasal Sinus Tumors. Vet. Radiol. Ultrasound39, 475–481 (1998).
29.
WelshJ. S.TurekM.MackieT. R.Conformal Avoidance Helical Tomotherapy for Dogs with Nasopharyngeal Tumors. Proc. 12th Int. Congr. Rad. Res. 146 (abstr PP14/0447) (2003).
30.
BoothJ. T.ZavgorodniS. F.Set-up Error & Organ Motion Uncertainty: A Review. Australasian Physical Eng. Sci. Med.22, 29–47 (1999).
31.
MartelM. K.Ten HakenR. K.HazukaM. B.Estimation of Tumor Control Probability Model Parameters From 3-D Dose Distributions of Non-Small Cell Lung Cancer Patients. Lung Ca.24, 31–37 (1999).
32.
JonesL.MetcalfeP.HobanP.Accounting for Treatment Delays When Treating Highly Proliferative Tumors. Phys. Med. Biol.44, 223–234 (1999).
33.
HorwitzE. M.HanlonA. L.PinoverW. H.The Cost-effectiveness of 3D Conformal Radiation Therapy Compared with Conventional Techniques for Patients with Clinically Localized Prostate Cancer. Int. J. Radiat. Oncol. Biol. Phys.45, 1219–1226 (1999).
34.
LegorretaA. P.BrooksR. H.LeibowitzA. N.Cost of Breast Cancer Treatment. A 4-year Longitudinal Study. Archives of Int. Med.156, 2197–2201 (1996).
35.
FowlerJ. F.ChappellR.Non-small Cell Lung Tumors Repopulate Rapidly During Radiation Therapy. Int. J. Radiat. Oncol. Biol. Phys.46, 516–517 (2000).
36.
CoxJ. D.PajakT. F.AsbellS.Interruptions of High-dose Radiation Therapy Decrease Long-term Survival of Favorable Patients with Unresectable Non-small Cell Carcinoma of the Lung: Analysis of 1244 Cases from 3 Radiation Therapy Oncology Group (RTOG) Trials. Int. J. Radiat. Oncol. Biol. Phys.27, 493–498 (1993).
37.
KwaS. L.LebesqueJ. V.TheuwsJ. C.Radiation Pneumonitis as a Function of Mean Lung Dose: An Analysis of Pooled Data of 540 Patients. Int. J. Radiat. Oncol. Biol. Phys.42, 1–9 (1998).
38.
MehtaM.ScrimgerR.MackieT. R.PaliwalB.ChappellR.FowlerJ.A New Approach to Dose Escalation in Non-small Cell Lung Cancer. Int. J. Radiat. Oncol. Biol. Phys.49, 23–33 (2001).
39.
WithersH. R.TaylorJ. M. G.MaciejewskiB.The Hazard of Accelerated Tumor Clonogen Repopulation During Radiotherapy. Acta. Oncol.27, 131–146 (1988).
40.
RobertsS. A.HendryJ. H.The Delay Before Onset of Accelerated Tumor Cell Repopulation During Readiotherapy: A Direct-maximum Likelihood Analysis of a Collection of Worldwide Tumor-control Data. Radiother. Oncol.29, 69–74 (1993).
41.
BrennerD. J.. Accelerated Repopulation During Radiotherapy: Quantitative Evidence for Delayed Onset. Radiat. Oncol. Invest.1, 167–172 (1993).
42.
ScrimgerR. A.TomeW. A.OliveraG. H.ReckwerdtP. J.MehtaM. P.FowlerJ. F.Reduction in Radiation Doses to Lung and Other Normal Tissues Using Helical Tomotherapy to Treat Lung Cancer, in Comparison to Conventional Field Arrangements. Am. J. Clin. Oncol.26, 70–78 (2003).
43.
HanksG. E.MartzK. L.DiamondJ. J.The Effect of Dose on Local Control of Prostate Cancer. Int. J. Radiat. Oncol. Biol. Phys.15, 1299–1305 (1988).
44.
PerezC. A.WalzB. J.ZivnuskaF. R.Irradiation of Carcinoma of the Prostate Localized to the Pelvis: Analysis of Tumor Response and Prognosis. Int. J. Radiat. Oncol. Biol. Phys.6, 555–563 (1980).
45.
PollackA.ZagarsG. K.SmithI. G.Preliminary Results of a Randomized Dose-escalation Study Comparing 70 Gy to 78 Gy for the Treatment of Prostate Cancer. Int. J. Radiat. Oncol. Biol. Phys.45, 146–147 (1999).
46.
HanksG. E.Optimizing the Radiation Treatment and Outcome of Prostate Cancer. Int. J. Radiat. Oncol. Biol. Phys.11, 1235–1245 (1985).
47.
MichalskiJ. M.RoachM.VijayakumarS.Preliminary Report of Toxicity Following 3D Radiation Therapy for Prostate Cancer on 3DOG/RTOG 9406. Int. J. Radiat. Oncol. Biol. Phys.46, 391–402 (2000).
48.
ZelefskyM. J.FuksZ.HuntM.High-dose Intensity Modulated Radiation Therapy for Prostate Cancer: Early Toxicity and Biochemical Outcome in 772 Patients. Urol. Oncol.21, 306–307 (2003).
49.
HaustermansK. M. H.HoflandI.van PoppelH.Cell Kinetic Measurements in Prostate Cancer. J. Radiat. Oncol. Biol. Phys.197, 1067–1070.
50.
BrennerD. J.HallE. J.Fractionation and Protraction for Radiotherapy of Prostate Carcinoma. Int. J. Radiat. Oncol. Biol. Phys.43, 1095–1101 (1999).
51.
FowlerJ. J.ChappellR.RitterM.Int. J. Radiat. Oncol. Biol. Phys.50, 1021–1031 (2001).
DuschesneG. M.PetersL. J.What is the Alpha/Beta Ratio for Prostate Cancer? Rationale for Hypofractionated High-Dose-Rate Brachytherapy. J. Radiat. Oncol. Biol. Phys.44, 747–748 (1999).
54.
PatelR. R.OrtonN.TomeW. A.Rectal Dose Sparing with a Balloon Catheter and Ultrasound Localization in Conformal Radiation Therapy for Prostate Cancer. Radiother. Oncol.67, 285–294 (2003).
55.
MenkeM.HirschfeldF.MackT.Photogrametric Accuracy Measurements of Head Holder Systems used for Fractionated Radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.24, 781–787 (1992).
56.
DelannesM.DalyN. J.BonnetJ.Fractionated Radiotherapy of Small Inoperable Lesions of the Brain Using a Noninvasive Stereotactic Frame. Int. J. Radiat. Oncol. Biol. Phys.21, 749–755 (1991).
57.
LaingR. W.ThompsonV.WarringtonA. P.Feasibility of Patient Immobilization for Conventional Cranial Irradiation with Relocatable Stereotactic Frame. Br. J. Radiol.66, 1020–1024 (1993).
ToméW. A.MeeksS. L.BuattiJ. M.A High-precision System for Conformal Intracranial Radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.47, 1137–1143 (2000).
60.
BouchetL. G.MeeksS. L.GoodchildG.Calibration of Three-dimensional Ultrasound Images for Image-guided Radiation Therapy. Phys. Med. Biol.46, 559–577 (2001).
61.
FordE. C.MageraG. S.YorkeE.Evaluation of Respiratory Movement During Gated Radiotherapy Using Film and Electronic Portal Imaging. Int. J. Radiat. Oncol. Biol. Phys.52, 522–531 (2002).
62.
ToméW. A.FowlerJ. F.Selective Boosting of Tumor Subvolumes. Int. J. Radiat. Oncol. Biol. Phys.48, 593–599 (2000).
63.
ToméW. A.FowlerJ. F.Cold On Spots in Tumor Tubvolumes. Med. Phys.29, 1590–1598 (2002).
64.
WelshJ.OliveraG.HuiS.Helical Tomotherapy with Conformal Avoidance Appears Superior to 3-D CRT and IMRT for Treatment of Complex Tumor volumes. Radiother. Oncol.64 (Suppl 1) S124 (2002).
65.
PouliotJ.Bani-HashemiA.ChenJ.SvatosM.Low-dose Megavoltage Cone-beam CT for Radiation Therapy. Int. J. Radiat. Oncol. Biol. Phys.61, 552–560 (2005).
66.
OrtonN.JaradatH.WelshJ. S.TomeW.Whole Scalp Irradiation using Helical Tomotherapy. Medical Dosimetry.30, 162–168 (2005).
67.
KhuntiaD.JaradatH.OrtonN.MehtaM. P.TomeW.WelshJ. S.Helical Tomotherapy as a Means of Administering Total or Partial Scalp Irradiation. Int. J. Radiat. Oncol. Biol. Phys.64, 1288–1289 (2006).
68.
HuiS. K.KapatoesJ.FowlerJ.HendersonD.OliveraG.ManonR. R.GerbiB.MackieT. R.WelshJ. S.Feasibility Study of Helical Tomotherapy for Total Body or Total Marrow Irradiation. Med. Phys.32, 3214 (2005).
69.
WelshJ. S.PetersonC.KahlB.OliveraG.Radiotherapy for Hodgkin's Disease and Non-Hodgkin's Lymphoma Using Intensity Modulated Radiation Therapy Via Helical Tomotherapy: A New Mantle. In Intensity Modulated Radiation Therapy: A Clinical Perspective. Eds., MundtA. J. and RoeskeJ. C.BC Decker Inc Publishers (2005).
70.
VinebergK. A.EisbruchA.CoselmonM. M.Is Uniform Target Dose Possible in IMRT Plans in the Head and Neck?Int. J. Radiat. Oncol. Biol. Phys.52, 1159–1172 (2002).
